Argenx
ARGX
#573
Rank
A$56.72 B
Marketcap
$948.66
Share price
-1.94%
Change (1 day)
37.71%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: A$56.72 Billion

As of December 2024 Argenx has a market cap of A$56.72 Billion. This makes Argenx the world's 573th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024A$56.72 B71.26%
2023A$33.12 B7.55%
2022A$30.79 B21.41%
2021A$25.36 B39.11%
2020A$18.23 B85.61%
2019A$9.82 B97.4%
2018A$4.97 B93.8%
2017A$2.56 B
2014A$0.17 B

End of Day market cap according to different sources

On Dec 9th, 2024 the market cap of Argenx was reported to be:

A$56.72 Billion
by Yahoo Finance info icon info icon
A$56.72 Billion
by CompaniesMarketCap info icon info icon
A$56.15 Billion
by Nasdaq info icon info icon